title: Approach and avoidance coping: diurnal cortisol rhythm in prostate cancer survivors.
abstract: Psychological coping responses likely modulate the negative physiological consequences of cancer-related demands. This longitudinal, observational study examined how approach- and avoidance-oriented strategies for coping with cancer are associated with diurnal cortisol rhythm in prostate cancer (PC) survivors. Sixty-six men (M age=65.76; SD=9.04) who had undergone radical prostatectomy or radiation therapy for localized PC within the prior two years reported their use of approach and avoidance coping via questionnaire at study entry (T1). Participants provided saliva samples (3 times per day over 3 days) for diurnal cortisol assessment at T1 and again 4 months later (T2). When controlling for relevant biobehavioral covariates, cancer-related avoidance-oriented coping was associated with flatter cortisol slopes at T1 (B=.34, p=.03) and at T2 (B=.30, p=.02). Approach-oriented coping was not associated with cortisol slopes. Post-hoc analyses revealed a significant interaction between avoidant coping and time since completion of cancer treatment on T2 cortisol slope (B=-.05, p=.04). Men who used relatively more avoidance-oriented coping who were further in time from treatment demonstrated a flatter cortisol slope. High avoidance-oriented coping is associated with dysregulation of cortisol responses, which may be an important target for reducing stress during PC survivorship.
authors.affiliation: Department of Psychology, Hunter College, City University of New York, New York, NY, United States; Department of Psychology, Graduate Center, City University of New York, New York, NY, United States. Electronic address: michael.hoyt@hunter.cuny.edu.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Hoyt
authors.affiliation: Department of Psychology, Hunter College, City University of New York, New York, NY, United States; Department of Psychology, Graduate Center, City University of New York, New York, NY, United States.
authors.forename: Amanda M
authors.initials: AM
authors.lastname: Marin-Chollom
authors.affiliation: Department of Psychology, University of California, Los Angeles, Los Angeles, CA, United States; Cousins Center for Psychoneuroimmunology, Semel Institute, University of California, Los Angeles, Los Angeles, CA, United States; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States.
authors.forename: Julienne E
authors.initials: JE
authors.lastname: Bower
authors.affiliation: Department of Psychology, Pitzer College, Claremont University Consortium, Claremont, CA, United States.
authors.forename: KaMala S
authors.initials: KS
authors.lastname: Thomas
authors.affiliation: Department of Psychology, University of California, Los Angeles, Los Angeles, CA, United States; Cousins Center for Psychoneuroimmunology, Semel Institute, University of California, Los Angeles, Los Angeles, CA, United States; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Irwin
authors.affiliation: Department of Psychology, University of California, Los Angeles, Los Angeles, CA, United States; Cousins Center for Psychoneuroimmunology, Semel Institute, University of California, Los Angeles, Los Angeles, CA, United States; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States.
authors.forename: Annette L
authors.initials: AL
authors.lastname: Stanton
mesh_terms: D000223:Adaptation, Psychological / Q000502:physiology*; D000368:Aged; D002940:Circadian Rhythm / Q000502:physiology*; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000378:metabolism / Q000523:psychology*; D012463:Saliva / Q000378:metabolism; D017741:Survivors / Q000523:psychology*
chemical_list: D006854:Hydrocortisone
keywords: Approach coping; Avoidance coping; Diurnal cortisol; Prostate cancer
references.citation: Int J Behav Med. 1997;4(1):92-100
references.pmid: 16250744
references.citation: Psychoneuroendocrinology. 2008 Jun;33(5):601-11
references.pmid: 18329182
references.citation: PLoS One. 2012;7(8):e42324
references.pmid: 22870317
references.citation: Psychol Bull. 2003 Mar;129(2):216-269
references.pmid: 12696840
references.citation: Psychoneuroendocrinology. 2014 Jun;44:83-7
references.pmid: 24767622
references.citation: J Pers Soc Psychol. 2000 Jun;78(6):1150-69
references.pmid: 10870915
references.citation: Brain Behav Immun. 2013 Aug;32:173-9
references.pmid: 23624266
references.citation: Ann Behav Med. 2006 Dec;32(3):235-44
references.pmid: 17107297
references.citation: Brain Behav Immun. 2013 Mar;30 Suppl:S19-25
references.pmid: 22728325
references.citation: J Clin Oncol. 2006 Nov 10;24(32):5132-7
references.pmid: 17093275
references.citation: Brain Behav Immun. 2013 Mar;30 Suppl:S163-70
references.pmid: 22884416
references.citation: Psychoneuroendocrinology. 2004 Sep;29(8):1082-92
references.pmid: 15219660